FDA Approves Pitolisant for Treatment of Narcolepsy
Yesterday, Harmony Biosciences announced FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy. Read
Yesterday, Harmony Biosciences announced FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy. Read
In recognition of Father’s Day, TREND Community honors community member Rick Karl. Rick is the president of the Cure for Tay-Sachs organization (www.curetaysachs.org) which has
WENDY WHITEAdvisor Wendy White is an innovative leader working for over 20 years in Rare Disease at the intersection of advocacy, technology and business. She